The breakdown of T cell tolerance is a pinnacle pathogenic event in rheumatoid arthritis (RA) and precedes the onset of clinical disease by decades. Molecular analyses of T cells supported by this project has led to the discovery that RA T cells are prematurely aged and that senescence supports proinflammatory effector functions. Recent work has connected maldifferentiation of RA T cells with abnormalities in their energy supply and metabolism. Metabolic abnormalities are present in nave CD4 T cells, long before they participate in synovial inflammation, opening the intriguing possibility to prevent autoimmunity by metabolic interference. Nave CD4 T cells in RA patients downregulate the glycolytic enzyme Phosphofructokinase 2 (PFKFB3) and upregulate Glucose-6-phosphate dehydrogenase (G6PD); therefore shunting glucose into the pentose phosphate pathway (PPP). This metabolic abnormality leads to an oversupply of reductive elements (NADPH) and consumption of reactive oxygen species (ROS), resulting in defective oxidant signaling. Mostly affected is the redox-sensing protein kinase Ataxia telangiectasia mutated (ATM), which controls cell cycle behavior. With ATM insufficiency, RA T cells hyperproliferate, loose quiescence and make an early commitment to IL-17 and IFN-? production. This project will define molecular mechanisms that connect metabolic and functional abnormalities in RA T cells, with the aim to identify actionable diagnostic and therapeutic targets. We have developed a panel of pharmacologic and genetic manipulations to mimic PPP overutilization in human T cells, enabling a mechanistic exploration of T cell metabolism and function.
Specific Aim 1 will seek to understand how glucose shunting into the PPP, accumulation of NADPH and loss of ROS affects T cell differentiation, survival and senescence; with a special emphasis on the induction of disease- relevant T follicular helper cells and Treg cells.
Specific Aim 2 will determine how metabolic reprogramming affects the interaction of T cells with B cells, osteoclast precursors and synoviocytes to clarify its impact on autoantibody production, bone erosion and synovial hyperplasia.
In Specific Aim 3, we will examine the regulatory role of inflammatory signals in the glycolytic machinery, specifically in the induction and suppression of PFKFB3 and G6PD.
Specific Aim 4 is designed to discover how oxidant signaling shapes T cell differentiation and lineage commitment. By focusing on ATM, AMPK and mTOR we will define relevant signaling pathways and identify small molecule reagents that can restore ATM and AMPK activation, thus restraining mTOR and mTOR-dependent inflammation.

Public Health Relevance

Rheumatoid arthritis is a chronic inflammatory joint disease caused by a dysfunctional immune system. In patients with RA the 'master regulators' of the immune system, CD4 T cells, are pre-aged and have a defect in their energy supply. This proposal seeks to identify new ways of manipulating the energy metabolism of T cells, such that these T cells can be reeducated and reintegrated into a healthy immune system.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR042527-23
Application #
9663873
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Mao, Su-Yau
Project Start
1993-09-30
Project End
2022-01-31
Budget Start
2020-02-01
Budget End
2021-01-31
Support Year
23
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Weyand, Cornelia M; Goronzy, Jörg J (2018) A Mitochondrial Checkpoint in Autoimmune Disease. Cell Metab 28:185-186
Ye, Zhongde; Li, Guangjin; Kim, Chulwoo et al. (2018) Regulation of miR-181a expression in T cell aging. Nat Commun 9:3060
Zhang, Hui; Watanabe, Ryu; Berry, Gerald J et al. (2018) Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis. Circulation 137:1934-1948
Uribe, Jorge A; Aggarwal, Ishita; Witthayaweerasak, Juthamat et al. (2018) Refractory Giant Cell Arteritis Complicated by Vision Loss From Optic Atrophy and Maculopathy Associated With Pachymeningitis. J Neuroophthalmol 38:17-23
Gustafson, Claire E; Cavanagh, Mary M; Jin, Jun et al. (2018) Functional pathways regulated by microRNA networks in CD8 T-cell aging. Aging Cell :e12879
Li, Yinyin; Goronzy, Jörg J; Weyand, Cornelia M (2018) DNA damage, metabolism and aging in pro-inflammatory T cells: Rheumatoid arthritis as a model system. Exp Gerontol 105:118-127
Goronzy, Jörg J; Hu, Bin; Kim, Chulwoo et al. (2018) Epigenetics of T cell aging. J Leukoc Biol 104:691-699
Kim, Chulwoo; Hu, Bin; Jadhav, Rohit R et al. (2018) Activation of miR-21-Regulated Pathways in Immune Aging Selects against Signatures Characteristic of Memory T Cells. Cell Rep 25:2148-2162.e5
Watanabe, Ryu; Maeda, Toshihisa; Zhang, Hui et al. (2018) MMP (Matrix Metalloprotease)-9-Producing Monocytes Enable T Cells to Invade the Vessel Wall and Cause Vasculitis. Circ Res 123:700-715
Weyand, Cornelia M; Shen, Yi; Goronzy, Jorg J (2018) Redox-sensitive signaling in inflammatory T cells and in autoimmune disease. Free Radic Biol Med 125:36-43

Showing the most recent 10 out of 200 publications